Wanbury Limited (BOM:524212)

Market Cap	6.18B
Revenue (ttm)	6.31B
Net Income (ttm)	501.45M
Shares Out	34.89M
EPS (ttm)	14.97
PE Ratio	11.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,307
Average Volume	5,175
Open	196.20
Previous Close	198.65
Day's Range	178.00 - 196.20
52-Week Range	155.00 - 330.00
Beta	-0.10
RSI	25.76
Earnings Date	Feb 10, 2026

About Wanbury

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its n...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 1,382
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524212

Financial Performance

In 2024, Wanbury's revenue was 6.00 billion, an increase of 3.88% compared to the previous year's 5.78 billion. Earnings were 305.30 million, a decrease of -45.44%.